Literature DB >> 16636117

Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing's disease.

Robert J Weil1, Alexander O Vortmeyer, Lynnette K Nieman, Hetty L Devroom, John Wanebo, Edward H Oldfield.   

Abstract

CONTEXT: Partial or total removal of the pituitary cures 60-80% of patients with Cushing's disease (CD) in whom an adenoma cannot be identified at surgery. Many patients who fail complete or partial hypophysectomy are cured by sellar and parasellar irradiation. DESIGN/PATIENTS: As part of a series of prospective studies of CD, we identified 12 patients (34.5 +/- 19.9 yr; 11 females; four children) with tumors located completely within the neurohypophysis among 730 patients undergoing surgery for CD.
SETTING: The study was conducted at a tertiary referral center at a clinical research hospital.
RESULTS: All 12 patients had clinical and biochemically defined CD. Tumor was visible at surgery in 11 patients; all 12 tumors were positive for ACTH by immunohistochemistry. Two tumors were excised at repeat surgery because of persistent hypercortisolism within 14 d of negative exploration of the adenohypophysis. There were no long-term complications. At follow-up of 71.9 +/- 34.2 months (range, 30-138 months), all patients are in remission of CD. Adult patients have had significant improvement in weight and body mass indices, with restoration of normal menses in all women. In the four pediatric patients, height, weight, and body mass indices have been restored toward normal by surgical remission of CD. Hypopituitarism or long-term neurohypophysial dysfunction has not occurred.
CONCLUSION: We report a new subset of patients with CD, ACTH-secreting adenomas that arise wholly within the posterior lobe of the pituitary gland. In cases of CD in which an adenoma is not identified in the adenohypophysis and in patients with persistent hypercortisolism after complete or partial excision of the anterior lobe, tumor within the neurohypophysis should be considered; selective adenomectomy of a neurohypophyseal, ACTH-secreting tumor can produce long-term remission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636117     DOI: 10.1210/jc.2006-0277

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Endoscopic endonasal infrasellar approach to the sellar and suprasellar regions: technical note.

Authors:  Alessandro Paluzzi; Juan C Fernandez-Miranda; Carlos Pinheiro-Neto; Victor Alcocer-Barradas; Beatriz Lopez-Alvarez; Paul Gardner; Carl Snyderman
Journal:  Skull Base       Date:  2011-09

Review 2.  Surgical management of Cushing's disease.

Authors:  Robert F Dallapiazza; Edward H Oldfield; John A Jane
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

3.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

Review 4.  The pseudocapsule surrounding a pituitary adenoma and its clinical significance.

Authors:  Xin Qu; Guangming Xu; Yuanming Qu; Tao Song
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.130

Review 5.  Ectopic ACTH-secreting pituitary adenomas within the sphenoid sinus.

Authors:  Philip C Johnston; Laurence Kennedy; Robert J Weil; Amir H Hamrahian
Journal:  Endocrine       Date:  2014-06-14       Impact factor: 3.633

6.  Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.

Authors:  Russell R Lonser; Alexander Ksendzovsky; Joshua J Wind; Alexander O Vortmeyer; Edward H Oldfield
Journal:  J Neurosurg       Date:  2011-09-16       Impact factor: 5.115

7.  An unusual presentation of pediatric Cushing disease: recurrent corticotropinoma of the posterior pituitary lobe.

Authors:  Monalisa F Azevedo; Paraskevi Xekouki; Meg F Keil; Eileen Lange; Nicholas Patronas; Constantine A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2010-06       Impact factor: 1.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.